1.
Lechowska Z, Piotrowska G, Gaczoł AA, Król W, Kulka K, Jurczak D, et al. NATALIZUMAB IN MULTIPLE SCLEROSIS – A REVIEW OF DIFFERENT DOSING REGIMENS, SIDE EFFECTS, COMPARISON WITH OTHER DISEASE-MODIFYING THERAPIES WITH ADDITIONAL ATTENTION TO USE IN PREGNANCY AND THE PEDIATRIC POPULATION. IJITSS [Internet]. 2026 Aug. 25 [cited 2026 Sep. 12];2(3(51). Available from: https://rspublisher.org/index.php/ijitss/article/view/5801